Repligen Corp (RGEN)

CAPS Rating:

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.

View All Commentary (RGEN)

Recs

2

Avatar carolchris95 (51.67) Submitted: 3/31/08 11:26 AM : Start Price: $4.82 RGEN Score: 18.97

Repligen Corp. is filling a voild with it's research and products.

This stock has an excellent PE ratio and a good profit margin.

I see this stock hiiting the $10 -12 for share within 18 months.

Maybe sooner depending the results of the clinical trials.

Report this Post Replies: 2 | Reply

Avatar maxumtrades (< 20) Submitted: 5/22/08 10:48 PM

Recs: 0 | Rec This

This stock is already trading at what 7.00 per share. In 18 months I see this stock at 17.00 per share.
They have good financials while i am a technical trader. Their books look good. They expect better than average profit.
This stock is a great long stock.
It has done wonders for me trading on the shorter end.

Report this Post Reply

Avatar carolchris95 (51.67) Submitted: 5/30/08 9:46 PM

Recs: 0 | Rec This

I agree 100 percent. This stock is a keeper.

Report this Post Reply

Repligen Corp (RGEN)

2

Featured Broker Partners